Sulfatide Binds to Influenza B Virus and Enhances Viral Replication., PMID:40284974
Dual roles of influenza B virus neuraminidase mRNA vaccine in enhancing cross-lineage protection by supplementing inactivated split vaccination., PMID:40265888
Influenza A hemagglutinin virus-like particles confer protection against influenza B virus infection., PMID:40230200
A monoclonal anti-hemagglutinin stem antibody modified with zanamivir protects against both influenza A and B viruses., PMID:40193611
Selection and identification of an ssDNA aptamer against influenza B virus hemagglutinin protein., PMID:40050943
A novel tetravalent influenza vaccine based on one chimpanzee adenoviral vector., PMID:40023902
Adenoviral-Vectored Multivalent Vaccine Provides Durable Protection Against Influenza B Viruses from Victoria-like and Yamagata-like Lineages., PMID:40004004
A single mutation at position 214 of influenza B hemagglutinin enhances cross-neutralization., PMID:39960410
Host-microbe multiomic profiling identifies distinct COVID-19 immune dysregulation in solid organ transplant recipients., PMID:39794319
Preclinical evaluation of a universal inactivated influenza B vaccine based on the mosaic hemagglutinin-approach., PMID:39551795
Hemagglutination-Inhibition Antibodies and Protection against Influenza Elicited by Inactivated and Live Attenuated Vaccines in Children., PMID:39504434
Improved influenza vaccine responses after expression of multiple viral glycoproteins from a single mRNA., PMID:39379405
Molecular epidemiology and vaccine compatibility analysis of seasonal influenza A viruses in the context of COVID-19 epidemic in Wuhan, China., PMID:39370830
Triton X-100-treated virus-based ELLA demonstrates discordant antigenic evolution of influenza B virus hemagglutinin and neuraminidase., PMID:39360825
Antigenic analysis of the influenza B virus hemagglutinin protein., PMID:39233140
Evaluation of a qualified MDCK cell line for virus isolation to develop cell-based influenza vaccine viruses with appropriate antigenicity., PMID:39213922
Intranasal administration of octavalent next-generation influenza vaccine elicits protective immune responses against seasonal and pre-pandemic viruses., PMID:39171925
Disulfide-stabilized trimeric hemagglutinin ectodomains provide enhanced heterologous influenza protection., PMID:39101691
Safety and Immunogenicity of Respiratory Syncytial Virus Prefusion F Protein Vaccine when Co-administered with Adjuvanted Seasonal Quadrivalent Influenza Vaccine in Older Adults: A Phase 3 Randomized Trial., PMID:39099085
Host-microbe multiomic profiling reveals age-dependent immune dysregulation associated with COVID-19 immunopathology., PMID:38630846
Impact of sex on humoral immunity with live influenza B virus vaccines in mice., PMID:38409236
Protective human antibodies against a conserved epitope in pre- and postfusion influenza hemagglutinin., PMID:38147556
Influenza B virus neuraminidase: a potential target for next-generation vaccines?, PMID:38037386
A computationally optimized broadly reactive hemagglutinin vaccine elicits neutralizing antibodies against influenza B viruses from both lineages., PMID:37741893
Fc-Effector-Independent in vivo Activity of a Potent Influenza B Neuraminidase Broadly Neutralizing Antibody., PMID:37515226
ADCC: An underappreciated correlate of cross-protection against influenza?, PMID:36911705
Anti-neuraminidase and anti-hemagglutinin immune serum can confer inter-lineage cross protection against recent influenza B., PMID:36689429
Infant Antibody Repertoires during the First Two Years of Influenza Vaccination., PMID:36314798
Impact of adjuvant: Trivalent vaccine with quadrivalent-like protection against heterologous Yamagata-lineage influenza B virus., PMID:36248851
Broadly neutralizing antibodies recognizing different antigenic epitopes act synergistically against the influenza B virus., PMID:36039848
Impact of hemagglutination activity and M2e immunity on conferring protection against influenza viruses., PMID:35914365
A Hemagglutinin Stem Vaccine Designed Rationally by AlphaFold2 Confers Broad Protection against Influenza B Infection., PMID:35746776
[Expression of influenza B virus hemagglutinin and its immunogenicity determination]., PMID:35355478
Safety, Immunogenicity, and Protective Efficacy of an H5N1 Chimeric Cold-Adapted Attenuated Virus Vaccine in a Mouse Model., PMID:34960689
Functionality of the putative surface glycoproteins of the Wuhan spiny eel influenza virus., PMID:34697321
Cell-Adapted Mutations and Antigenic Diversity of Influenza B Viruses in Missouri, 2019-2020 Season., PMID:34696325
Mosaic Hemagglutinin-Based Whole Inactivated Virus Vaccines Induce Broad Protection Against Influenza B Virus Challenge in Mice., PMID:34603333
FluB-RAM and FluB-RANS: Genome Rearrangement as Safe and Efficacious Live Attenuated Influenza B Virus Vaccines., PMID:34452022
Epitope-targeting platform for broadly protective influenza vaccines., PMID:34043704
Influence of adjuvants on the amount, specificity and functional activity of antibody response to human influenza vaccine in mice., PMID:34022515
Next generation methodology for updating HA vaccines against emerging human seasonal influenza A(H3N2) viruses., PMID:33654128
Antibody Landscape Analysis following Influenza Vaccination and Natural Infection in Humans with a High-Throughput Multiplex Influenza Antibody Detection Assay., PMID:33531397
Safety, Immunogenicity, and Protective Efficacy of a Chimeric A/B Live Attenuated Influenza Vaccine in a Mouse Model., PMID:33513862
H1 Hemagglutinin Priming Provides Long-Lasting Heterosubtypic Immunity against H5N1 Challenge in the Mouse Model., PMID:33323511
Insights from the comparison of genomic variants from two influenza B viruses grown in the presence of human antibodies in cell culture., PMID:32925936
Characterization of Novel Cross-Reactive Influenza B Virus Hemagglutinin Head Specific Antibodies That Lack Hemagglutination Inhibition Activity., PMID:32907980
Airway Delivery of Anti-influenza Monoclonal Antibodies Results in Enhanced Antiviral Activities and Enables Broad-Coverage Combination Therapies., PMID:32847855
Monoclonal Antibody Therapy Protects Pharmacologically Immunosuppressed Mice from Lethal Infection with Influenza B Virus., PMID:32631823
Immune Pressure on Polymorphous Influenza B Populations Results in Diverse Hemagglutinin Escape Mutants and Lineage Switching., PMID:32168968
Hemagglutinin and Neuraminidase Antibodies Are Induced in an Age- and Subtype-Dependent Manner after Influenza Virus Infection., PMID:31941786
For research use only. Not for human or drug use.
